Gain Therapeutics, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €18.28K
    Gross profit
    -€18.28K
    SG&A expenses
    €7.20M
    R&D expenses
    €7.60M
    EBITDA
    -€14.76M
    D&A
    €54.58K
    EBIT
    -€14.80M
    Interest expenses
    €0.00
    EBT
    -€15.30M
    Tax expenses
    €649.89K
    Net income
    -€15.95M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €8.46M
    Changes in working capital
    -€2.18M
    Operating cash flow
    -€8.18M
    Capex
    €810.81
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€37.28K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €2.72M
    Debt repayment
    -€58.46K
    Other financing cash flow
    €4.17M
    Net financing cash flow
    €6.85M
    Foreign exchange effects
    -€83.90K
    Net change in cash
    -€8.78M
    Cash at end of period
    €5.77M
    Free cash flow
    -€8.18M

    Balance sheet

    Cash and cash equivalents
    €5.74M
    Cash and short-term investments
    €5.74M
    Total receivables
    €272.71K
    Inventory
    €0.00
    Other current assets
    €1.97M
    Total current assets
    €7.99M
    Property, plant & equipment
    €282.62K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €31.13K
    Other non-current assets
    €138.66K
    Total non-current assets
    €452.40K
    Total assets
    €8.44M
    Accounts payable
    €2.33M
    Short-term debt
    €116.96K
    Other current liabilities
    €1.99M
    Total current liabilities
    €4.46M
    Long-term debt
    €79.67K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €727.61K
    Total non-current liabilities
    €807.28K
    Total liabilities
    €5.27M
    Common stock
    €2.64K
    Retained earnings
    -€69.67M
    Other equity
    €501.14K
    Total equity
    €3.17M
    Total liabilities and shareholders' equity
    €8.44M

    Company information

    Market capitalization
    €50.32M
    Employees
    23
    Enterprise Value
    €44.71M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -503.1% Much worse than peer group: -74.0%
    ROA
    -189.1% Better than peer group: -202.2%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -16.3%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€693.60K

    Notifications